Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis ; Orphan D ...
Health experts have argued that UK customers are being hoodwinked by the drug firms behind the 'useless' medicines - which include Sudafed, Lemsip and Beechams.
Autolus has not yet disclosed the list price for Aucatzyl, which is also under review for market authorisation in the UK and ...
At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®â–¼ (erdafitinib) as a monotherapy for the treatment ...
And finally, the agency is making plans to pull it from pharmacy and grocery store shelves.The medicines will remain ...
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
The Consumer Healthcare Products Association, which represents manufacturers and marketers of over-the-counter medicines, ...
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback